CIK: 1283061 - Address: C/O Lantheus Holdings, Inc., 201 Burlington Road, South Building, Bedford, MA 01730
20 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret112-1310-827-261
S%wins100500505010058

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/29/23 17:51
3/27/23
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-1,07881.130-13-4119D
9/12/22 16:30
9/8/22
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS.d-3,52284.240-42-5633D
9/8/22 16:30
9/6/22
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS.d-13378.500-2-350D
7/12/19 16:05
7/10/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-13828.070-5-1528D
7/5/19 16:05
7/3/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-14228.410-5-1332D
6/28/19 16:30
6/26/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-13827.670-5-1237D
6/21/19 16:30
6/19/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-13727.400-5-1142D
6/14/19 16:30
6/12/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-12625.270-5-1047D
6/7/19 16:30
6/5/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-12324.600-5-952D
5/31/19 16:30
5/29/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-12124.290-5-857D
5/24/19 16:30
5/22/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-12424.730-5-762D
5/17/19 16:31
5/15/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-12424.750-5-767D
5/10/19 16:31
5/8/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-12625.220-5-672D
5/2/19 16:30
4/30/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS.m-24124.110-10-1177D
4/25/19 16:30
4/23/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-12024.070-5-587D
4/18/19 16:30
4/16/19
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian AMADS-12625.260-5-592D
11/21/17 17:00
11/20/17
IMMUImmunomedics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian ANJDS.d-10011.890-8-891D
8/25/16 17:01
8/23/16
IMMUImmunomedics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian ANJDS.d-452.983-15-1775D-224733-3925-3-10-4-10182977
6/15/15 16:31
6/12/15
IMMUImmunomedics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticMarkison Brian ANJDS.d-234.225-6-864D-111-8-11034-7052-44-24-26
3/4/10 17:09
3/3/10
KGKing Pharmaceuticals IncTNHealthDrugPharmaceutical PreparationsMarkison Brian ATNDOP,CEOS-81811.720-70-11562D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact